Human in Motion Robotics' self-balancing XoMotion exoskeleton has gained Canadian approval from Health Canada for use in ambulatory rehabilitation. XoMotion is scheduled to be available at rehabilitation centers in 2025 for spinal cord injury rehabilitation. Patients with neurological diseases and strokes can expect a future version to become available for physical therapy.
The self-balancing exoskeleton reduces the need for multiple assistants to prevent falls during ambulatory rehabilitation. This also reduces the fear of falling and allows patients to focus on their training rather than preventing falls. The exoskeleton handles users reaching for objects, bending over, sitting and standing, and walking down small steps.
The dexterity of the exoskeleton and self-balancing feature will ultimately allow users to independently walk about their homes and surroundings, but this aspect has not been demonstrated in real-world situations yet, unlike the Wandercraft Atalante X exoskeleton used to carry the Olympic Torch in Paris. The Wandercraft can also dynamically adjust to others bumping into the user. Whether the XoMotion exoskeleton can handle such situations has also not been revealed.
The XoMotion fits patients with a height between five feet and six feet four inches tall (1.52 to 1.93 m) and with a maximum weight of 220 pounds (99.8 kg). The exoskeleton is powered by hot-swappable batteries. The exoskeleton was developed by Simon Fraser University's School of Mechatronic Systems Engineering researchers.
Readers interested in developing robotic exoskeletons can read about the biomechanics in this book sold on Amazon. Those wanting to avoid the need for physical therapy should read how a modern, Western diet contributes to disease and disabilities in this book sold on Amazon.
Are you a techie who knows how to write? Then join our Team! Wanted:
- News Writer (Romania based)
Details here
Source(s)
Human in Motion Robotics Receives Approval to Market and Sell XoMotion™, The World's Most Advanced Medical Exoskeleton
News provided by Human in Motion Robotics Inc.
Sep 24, 2024, 10:17 ET
VANCOUVER, BC, Sept. 24, 2024 /PRNewswire/ - Human in Motion Robotics is proud to announce that XoMotion™, the world's most advanced exoskeleton, has received its first regulatory approval, clearing the way for it to be marketed and sold in Canada. Set to revolutionize ambulatory training in rehabilitation facilities, XoMotion is designed to aid patients with spinal cord injuries (SCI), stroke, and other neurological conditions by providing unparalleled support with its self-balancing and hands-free functionality.
A Leap Forward in Rehabilitation Technology
XoMotion stands out due to its ability to mimic natural, human-like movements, making it intuitive and easy to use for both patients and therapists. This innovative exoskeleton, rooted in advanced humanoid robotics, reduces the physical burden on therapists by lifting, assisting, mobilizing, and training patients, thus enhancing the safety and efficiency of rehabilitation programs.
Key Features of XoMotion™:
Self-Balancing: Ensures stability and safety during use.
Hands-Free: Allows for natural movement and normal upper body function.
Omnidirectional: Capable of performing a wide range of complex ambulatory tasks, providing true functionality.
Versatile: Suitable for a wide range of conditions, including SCI, stroke, and other neurological impairments, and safe for patients from acute to chronic stages of injury.
Safe: Reduces physical burden on therapists, enabling them to focus on patient care.
Global Expansion
Human in Motion Robotics recently received its Medical Devices Establishment License to market and sell XoMotion in Canada, marking a significant milestone as the first step toward providing widespread global access to patients and care providers. With this approval, XoMotion became the first self-balancing exoskeleton system available for acquisition in Canada. Looking ahead, the company will focus on gaining clearance in other important global markets, including the US, Asia, and the EU.
"With XoMotion, we are setting a new standard in rehabilitation technology. Our exoskeleton not only empowers patients by facilitating natural and functional movement but also supports therapists by reducing the physical demands of their work," said Siamak Arzanpour, CEO of Human in Motion Robotics. "Gaining regulatory approval from Health Canada is a crucial step towards our goal of global accessibility, and we are committed to continuing this progress in other key markets."
Availability
XoMotion is now available for acquisition in rehabilitation and research facilities in Canada and is globally available to scientific investigators conducting rehabilitation or robotics research. For more information visit humaninmotion.com, or to request a demonstration, please contact Human in Motion at [email protected]
About Human in Motion Robotics
Human in Motion Robotics is a leading innovator in robotic mobility and humanoid technology, dedicated to developing advanced solutions that improve patient outcomes and support healthcare professionals. Our mission is to transform the landscape of personal mobility through cutting-edge technology and customer-centric design.
For media inquiries, please contact:
Phil Astrachan
VP of Marketing
[email protected]
415-310-7466
SOURCE Human in Motion Robotics Inc.